Skip to content

Clinical trials

Observational COVID-19 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Observational Country / region: United States Clear all

504 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20161
20194
2020253
2021131
202255
202331
202415
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed324
Unknown status54
Recruiting38
Active, not recruiting35
Terminated30
Withdrawn14
Suspended4
Enrolling by invitation3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University17
National Institute of Allergy and Infectious Diseases (NIAID)16
Columbia University13
Mayo Clinic12
Pfizer12
M.D. Anderson Cancer Center10
Methodist Health System8
University of California, San Francisco8
Massachusetts General Hospital7
NYU Langone Health7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19504
Coronavirus Infections77
Post-Acute COVID-19 Syndrome19
Influenza, Human17
Severe Acute Respiratory Syndrome16
Virus Diseases10
Respiratory Distress Syndrome9
Hematologic Neoplasms8
Respiratory Insufficiency8
Respiratory Tract Infections8

Trials

Showing 1 to 25 of 504. Each trial links to its page on Pharma Observatory.

404 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.